Document text
Principal Investigator: Dorey Glenn
Organization: UNIV OF NORTH CAROLINA CHAPEL HILL
Fiscal Year: 2024
Award: $197,260
Funding agency: National Institute of Allergy and Infectious Diseases
ABSTRACT
Influenza and pneumococcal infections occurring in individuals with glomerular disease are preventable
contributors to excess healthcare utilization, morbidity, and mortality, and occur at a rate approximately 30 times
higher among individuals with glomerular diseases compared to the general US population. Vaccination is a
powerful and cost-effective method to reduce infectious burden, however, vaccine immunogenicity and
effectiveness have not been adequately studied in this high-risk patient population. Vaccination may not yield
protective or sustained immune responses in individuals with glomerular disease as a result of exposure to
immunosuppressive medications, altered immune cell function, and urinary loss of immunoglobulin and
complement factors. As a result, there remain pressing questions regarding whether these antibodies confer in-
vivo protection from influenza and pneumococcal infection. Evidence gaps that need to be addressed in
preparation for pragmatic trials focused on infection-prevention measures in this population include frequency of
administration of recommended vaccines, pervasiveness of infectious complications, and rates of influenza and
pneumococcal vaccine seroconversion and seroprotection. Prior studies have been limited by small sample size,
insufficiently characterized cohorts, and the use of assays that measure non-opsonic, and thus potentially non-
functional, antibodies.
The objective of this proposal is to describe the association of influenza and pneumococcal vaccination with
influenza and pneumococcal infections and describe functional vaccine immunogenicity in patients with
glomerular disease. Three projects have been proposed to achieve this objective: an analysis of influenza and
pneumococcal vaccine use and effectiveness in a nationwide healthcare claims database (MarketScan®), a
study examining vaccine immunogenicity in the multicenter NIDDK-sponsored Cure Glomerulonephropathy
(CureGN) study, and creation of a multicenter cohort to examine 23-valent pneumococcal vaccine
immunogenicity in children with nephrotic syndrome. The primary hypothesis is that, independent of kidney
function, rates of influenza and pneumococcal infection and suboptimal vaccine response will be higher in
individuals with active glomerular disease, greater immunosuppression exposure, greater proteinuria, and
younger age. Dr. Glenn’s career development goals include gaining advanced training in statistical methods and
epidemiologic study design, with a focus on the analysis of longitudinal datasets, healthcare claims data, and
multicenter vaccine immunogenicity studies. Dr. Glenn will receive mentorship from Dr. Amy Mottl and Dr. Ronald
Falk, both experts in the field of glomerular kidney disease. Additionally, Dr. Glenn will have a scientific advisory
committee comprised of experts in vaccine immunogenicity, infectious disease, healthcare claims data analysis,
and epidemiology. This work will inform the development of an R01 application in which Dr. Glenn leads a
pragmatic trial investigating pneumococcal vaccination strategies among children with nephrotic syndrome.
Terms: <0-11 years old><21+ years old><Acceleration><Address><Adult><Adult Human><Advisory Committees><Age><Antibiotic Agents><Antibiotic Drugs><Antibiotics><Antibodies><Antibody titer measurement><Assay><Attenuated><Bioassay><Biological Assay><Biopsy><Cause of Death><Cell Function><Cell Physiology><Cell Process><Cellular Function><Cellular Physiology><Cellular Process><Characteristics><Child><Child Youth><Children (0-21)><Clinical><Communicable Diseases><Complement><Complement Proteins><D pneumoniae><D. pneumoniae><Data><Data Analyses><Data Analysis><Data Bases><Databases><Development><Diplococcus pneumoniae><Disease><Disorder><Drugs><Effectiveness><Epidemiologic Research><Epidemiologic Studies><Epidemiological Studies><Epidemiology><Epidemiology Research><Exposure to><Foundations><Frequencies><Glomerular disease><Goals><Grippe><Guidelines><Health Care Utilization><Healthcare><IgG Deficiency><Immune><Immune Globulins><Immune response><Immunes><Immunity><Immunoglobulins><Immunological response><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Impairment><Incidence><Individual><Infection><Infection prevention><Infectious Disease Pathway><Infectious Diseases><Infectious Disorder><Influenza><Influenza Vaccines><Kidney Diseases><Lead><Lower Respiratory Tract Infection><Lower respiratory infection><Measurement><Measures><Mediating><Medication><Mentorship><Methods><Miscellaneous Antibiotic><Monitor><Morbidity><Morbidity - disease rate><NIDDK><National Institute of Diabetes and Digestive and Kidney Diseases><Nephropathy><Nephrotic Syndrome><Orphan Disease><Participant><Patients><Pb element><Pharmaceutical Preparations><Pneumococcal Infections><Pneumococcal vaccine><Pneumococcus><Population><Preparation><Prevent infection><Preventative measure><Preventative strategy><Prevention Measures><Prevention strategy><Preventive measure><Preventive strategy><Prospective, cohort study><Proteinuria><Rare Diseases><Rare Disorder><Recommendation><Regimen><Renal Disease><Renal Glomerular Diseases and Syndromes><Renal function><Renal glomerular disease><Renal glomerular disease or syndrome><Renal glomerular disorder><Renal glomerular syndrome><Research><Research Design><Research Resources><Resources><Risk Factors><S pneumoniae><S. pneumoniae><Sample Size><Scientist><Selective IgG Immunodeficiency><Selective Immunoglobulin G Subclass Deficiency><Statistical Methods><Streptococcus pneumoniae><Streptococcus pneumoniae Infections><Streptococcus pneumoniae vaccine><Study Type><Subcellular Process><Task Forces><Testing><Time><Training><Vaccinated><Vaccination><Vaccines><Work><adulthood><advisory team><ages><analyzing longitudinal><antibody titering><attenuate><attenuates><career><career development><clinical practice><cohort><complementation><cost effective><data base><data interpretation><developmental><drug/agent><epidemiologic><epidemiologic investigation><epidemiological><epidemiology study><experience><flu infection><flu vaccine><flu virus infection><flu virus vaccine><health care><health care service use><health care service utilization><healthcare service use><healthcare service utilization><healthcare utilization><heavy metal Pb><heavy metal lead><high risk><high risk group><high risk individual><high risk people><high risk population><hospital care><host response><immune response to vaccination><immune response to vaccines><immune suppression><immune suppressive activity><immune suppressive function><immune system response><immunization strategy><immunogenicity><immunoresponse><immunosuppressive activity><immunosuppressive function><immunosuppressive response><in vivo><infected with flu><infected with flu virus><infected with influenza><infected with influenza virus><influenza infection><influenza virus infection><influenza virus vaccine><kidney disorder><kidney function><kids><longitudinal analysis><longitudinal data set><longitudinal dataset><mortality><orphan disorder><patient population><pneumococcal disease><pneumococcus infection><pragmatic effectiveness trial><pragmatic trial><preparations><prophylactic><prospective><renal disorder><seroconversion><statistic methods><study design><urinary><vaccination strategy><vaccine against flu><vaccine against influenza><vaccine associated immune response><vaccine effectiveness><vaccine immune response><vaccine immunogenicity><vaccine induced immune response><vaccine response><vaccine responsiveness><vaccine-induced response><youngster>